BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36936907)

  • 21. Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis.
    Liao J; Wei D; Sun C; Yang Y; Wei Y; Liu X
    BMC Nephrol; 2022 Dec; 23(1):393. PubMed ID: 36482367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
    Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
    Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study.
    Xiang F; Chen R; Cao X; Shen B; Liu Z; Tan X; Ding X; Zou J
    Hemodial Int; 2018 Jan; 22(1):82-92. PubMed ID: 28403540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte-to-C-Reactive Protein Ratio as a Novel Marker for Predicting Oncological Outcomes in Patients with Esophageal Cancer.
    Takeuchi M; Kawakubo H; Hoshino S; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
    World J Surg; 2021 Nov; 45(11):3370-3377. PubMed ID: 34383091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19.
    Ullah W; Basyal B; Tariq S; Almas T; Saeed R; Roomi S; Haq S; Madara J; Boigon M; Haas DC; Fischman DL
    J Clin Med Res; 2020 Jul; 12(7):415-422. PubMed ID: 32655735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer.
    Iseda N; Iguchi T; Hirose K; Itoh S; Honboh T; Sadanaga N; Matsuura H
    Am Surg; 2023 Nov; 89(11):4452-4458. PubMed ID: 35920820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic impact of the lymphocyte-to-C-reactive protein ratio in patients with unresectable or recurrent advanced gastric cancer treated with first- and second-line treatment.
    Matsunaga T; Saito H; Fukumoto Y; Kuroda H; Taniguchi K; Takahashi S; Osaki T; Iwamoto A; Fukuda K; Shimizu S; Shishido Y; Miyatani K; Fujiwara Y
    Surg Today; 2023 Aug; 53(8):940-948. PubMed ID: 36595075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients.
    Neuen BL; Leather N; Greenwood AM; Gunnarsson R; Cho Y; Mantha ML
    Ren Fail; 2016; 38(1):70-6. PubMed ID: 26540580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malnutrition Inflammation Score cut-off predicting mortality in maintenance hemodialysis patients.
    Borges MC; Vogt BP; Martin LC; Caramori JC
    Clin Nutr ESPEN; 2017 Feb; 17():63-67. PubMed ID: 28361749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
    Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
    Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort.
    Sasaki K; Shoji T; Kabata D; Shintani A; Okute Y; Tsuchikura S; Shimomura N; Tsujimoto Y; Nakatani S; Mori K; Shioi A; Inaba M; Emoto M
    J Atheroscler Thromb; 2021 Mar; 28(3):249-260. PubMed ID: 32741893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer.
    Ou W; Zhou C; Zhu X; Lin L; Xu Q
    Onco Targets Ther; 2021; 14():337-346. PubMed ID: 33469310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative infection-related mortality and lymphocyte-to-C-reactive protein ratio in patients undergoing on-pump cardiac surgery: a novel predictor of mortality?
    Pala AA; Gücü A; Sünbül SA; Sünbül A; Özçelik H; Seker IB; Karaca Ü; Göncü MT
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3686-3694. PubMed ID: 35647850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer.
    Nishi M; Shimada M; Tokunaga T; Higashijima J; Yoshikawa K; Kashihara H; Takasu C; Ishikawa D; Wada Y; Eto S; Yoshimoto T
    World J Surg Oncol; 2021 Jul; 19(1):201. PubMed ID: 34229704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lymphocyte-to-C-reactive protein ratio in COVID-19: an unexplored tool].
    Gandino IJ; Padilla MJ; Carreras M; Caballero V; López Griskan S; Carlos J; Ametla Y; Borodowski H; Ladelfa J; Themines S; Basta MC; Presas JL
    Medicina (B Aires); 2022; 82(5):689-694. PubMed ID: 36220025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of neutrophil-to-lymphocyte and lymphocyte-to-C-reactive protein ratios with COVID-19-related mortality.
    Albarrán-Sánchez A; González-Ríos RD; Alberti-Minutti P; Noyola-García ME; Contreras-García CE; Anda-Garay JC; Martínez-Ascencio LE; Castillo-López DJ; Reyes-Naranjo LA; Guízar-García LA; Flores-Padilla G; Ramírez-Rentería C
    Gac Med Mex; 2020; 156(6):553-558. PubMed ID: 33877103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epicardial adipose tissue radiodensity is associated with all-cause mortality in patients undergoing hemodialysis.
    Kwon SS; Choi K; Da Nam B; Lee H; Cho NJ; Park BW; Kim H; Noh H; Jeon JS; Han DC; Oh S; Kwon SH
    Sci Rep; 2021 Nov; 11(1):23090. PubMed ID: 34845284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.
    Zhang Q; Song MM; Zhang X; Ding JS; Ruan GT; Zhang XW; Liu T; Yang M; Ge YZ; Tang M; Li XR; Qian L; Song CH; Xu HX; Shi HP
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1466-1476. PubMed ID: 34337882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating angiopoietin-like protein 2 levels and mortality risk in patients receiving maintenance hemodialysis: a prospective cohort study.
    Morinaga J; Kakuma T; Fukami H; Hayata M; Uchimura K; Mizumoto T; Kakizoe Y; Miyoshi T; Shiraishi N; Adachi M; Izumi Y; Kuwabara T; Okadome Y; Sato M; Horiguchi H; Sugizaki T; Kadomatsu T; Miyata K; Tajiri S; Tajiri T; Tomita K; Kitamura K; Oike Y; Mukoyama M
    Nephrol Dial Transplant; 2020 May; 35(5):854-860. PubMed ID: 31840173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.